FINWIRES · TerminalLIVE
FINWIRES

Nutrien Upgraded to Outperform at Raymond James

By

Nutrien Ltd. (NTR.TO, NTR) was upgraded to Outperform from Market Perform at Raymond James.

Analyst Steve Hansen raised his price target on shares of the Canadian fertilizer company to US$90 from US$74.

Hansen said his improved outlook on Nutrient is based upon: "1) early-stage signs of improving crop price fundamentals; 2) rising NPK prices, including recent fly-ups in Nitrogen & Phosphate stemming from the US-Iran war; and 3) commensurate increases to our forecasts."

"While rising input costs (sulphur, fuel) and strained grower affordability represent competing near-term headwinds, we believe the net effect of these cross-currents will be higher durable earnings and FCF," the analyst said in a note to clients.

Related Articles

Research

Research Alert: CFRA Maintained Buy Rating On Suncor Energy Inc. As Free Funds Flows Grows 53%

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 4-STARS (Buy) rating and boost our target price to CAD103. This reflects a 8.0x EBITDA multiple and 18.0x earnings multiple based on our 2027 projections. We increased the EBITDA multiple in tandem with the industry multiple to reflect superior operational execution. The story is largely unchanged since the 2026 Investor Day, as Q1 proved to be another strong quarter of cash flow generation and value return. Upstream production reached 875.2k bbl/d, up 2.6% Y/Y. Refining throughput reached 497.8k bbl/d at 97% utilization, while refined product sales increased 13% to 680.9k bbl/d. Free funds flow grew 53% to CAD2.91B. The company returned CAD1.54B to shareholders through CAD825M in share repurchases and over CAD700M in dividends. We maintained our 2026 and 2027 EPS forecasts of CAD6.97 and CAD5.39, respectively.

$SU
Research

Research Alert: Su Maintained Buy As Free Funds Flows Grows 53%: Tp $75

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 4-STARS (Buy) rating and boost our target price to CAD103. This reflects a 8.0x EBITDA multiple and 18.0x earnings multiple based on our 2027 projections. We increased the EBITDA multiple in tandem with the industry multiple to reflect superior operational execution. The story is largely unchanged since the 2026 Investor Day, as Q1 proved to be another strong quarter of cash flow generation and value return. Upstream production reached 875.2k bbl/d, up 2.6% Y/Y. Refining throughput reached 497.8k bbl/d at 97% utilization, while refined product sales increased 13% to 680.9k bbl/d. Free funds flow grew 53% to CAD2.91B. The company returned CAD1.54B to shareholders through CAD825M in share repurchases and over CAD700M in dividends. We maintained our 2026 and 2027 EPS forecasts of CAD6.97 and CAD5.39, respectively.

$SU
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from CAD4.20 to CAD6.40, applying a price-to-sales multiple of 13x our 2026 sales-per-share view (CAD0.49 using a USD/CAD exchange rate of 0.73x). We adjust our 2026 loss per share (LPS) estimate to -USD0.19 from -USD0.23 and our 2027 LPS view to -USD0.11 from -USD0.15. BLDP reported Q1 2026 revenue of USD19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to USD5.1M) and stationary power (up 775% to USD5.2M), though Bus revenue declined 46% to USD6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to USD52.8M, while the total backlog fell 5% to USD112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.

$BLDP